Author

Olivia Pryor

Institution: TScan Therapeutics (United States)

Observed institutions: SQZ Biotech (United States), TScan Therapeutics (United States)

OpenAlex ID: A5082015288

Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity

2022 · Matthew G Booty, Kelan A Hlavaty, et al. · The Journal of Immunology · 23

141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants

2020 · Matthew Booty, Adam Stockmann, et al. · Journal for ImmunoTherapy of Cancer · 3

170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming

2020 · Emrah Ozay, Matthew Booty, et al. · Journal for ImmunoTherapy of Cancer · 2

357 Discovery of a novel MAGEC2 epitope for TCR-T adoptive cell therapy from expanded T cell clones of TIL therapy products

2023 · Andrew Ferretti, Adam Weinheimer, et al. · Journal for ImmunoTherapy of Cancer

Works count: 4

Citation count: 28

H-index: 2

I10-index: 1